1. Home
  2. BBUC vs RGEN Comparison

BBUC vs RGEN Comparison

Compare BBUC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Business Corporation Exchangeable Subordinate Voting Shares

BBUC

Brookfield Business Corporation Exchangeable Subordinate Voting Shares

N/A

Current Price

$31.46

Market Cap

6.6B

Sector

N/A

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$130.93

Market Cap

6.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBUC
RGEN
Founded
2022
1981
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.6B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
BBUC
RGEN
Price
$31.46
$130.93
Analyst Decision
Buy
Buy
Analyst Count
1
12
Target Price
$41.00
$167.67
AVG Volume (30 Days)
339.8K
1.1M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
0.75%
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.15
Revenue
N/A
$141,236,000.00
Revenue This Year
N/A
$14.30
Revenue Next Year
N/A
$14.52
P/E Ratio
N/A
$879.73
Revenue Growth
N/A
35.10
52 Week Low
$28.29
$100.99
52 Week High
$38.25
$175.77

Technical Indicators

Market Signals
Indicator
BBUC
RGEN
Relative Strength Index (RSI) 50.51 41.49
Support Level $29.29 $127.63
Resistance Level $31.92 $131.53
Average True Range (ATR) 1.03 6.21
MACD 0.15 -2.20
Stochastic Oscillator 79.90 11.05

Price Performance

Historical Comparison
BBUC
RGEN

About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares

Brookfield Business Corp is the operator of vital industrial and business services operations. The company focuses on acquiring market businesses for value, execute its operational improvement plans to increase cash flows and recycle capital to compound long-term growth. Geographically, it derives maximum revenue from the United States, and the rest from Europe, Brazil, Australia, Canada, and others. It operates in four segments within particular sectors namely: business services, infrastructure services, industrials, and corporate. The company derives maximum revenue from Industrials segment engaged in energy storage operations, engineered components manufacturing operations, water and wastewater operations, electric heat tracing systems manufacturer, and other industrials operations.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: